Eckenhoff R G, Shuman H
Department of Anesthesia, University of Pennsylvania Medical Center, Philadelphia 19104.
Anesthesiology. 1993 Jul;79(1):96-106. doi: 10.1097/00000542-199307000-00015.
Recently, halothane and isoflurane have been shown to bind in a saturable manner to serum albumin using NMR and gas chromatography methods. To validate a novel direct photoaffinity labeling method developed in our laboratory, the authors also determined the binding characteristics of halothane to serum albumin, and then extended this approach to other soluble proteins in an initial attempt to understand the interaction of volatile anesthetics and proteins.
Serum albumin (BSA), bacterial luciferase (BL), poly-(L-lysine)(PLL), and poly-(L-glutamate)(PLG) were dissolved in 0.154 M NaCl containing 14C-halothane with or without other volatile anesthetics or ligands, and exposed to 254 nm UV light for 10 s. Covalently bound label was quantitated by scintillation counting after precipitation, filtration, and washing. Binding parameters were calculated by nonlinear least-squares fitting of rectangular hyperbolas or logistic equations.
Serum albumin bound halothane in a saturable manner at an apparent KD between 0.3 and 0.5 mM. Other volatile anesthetics inhibited binding (KI, in mM): halothane (0.36), chloroform (1.26), methoxyflurane (2.66), isoflurane (1.47), diethyl ether (45.5), and ethanol (1,040). Oleate and BSA conformational changes (low pH) also inhibited label incorporation. Binding to BL and PLL at pH 7 was nonsaturable and not displaced by unlabeled halothane or the BL substrate decanal. Conversion of PLL to an alpha-helical conformation (pH > 10) increased binding and created a saturable component with an apparent KD of 0.55 mM. Alkaline conditions decreased binding to PLG consistent with the loss of alpha-helical domains.
Photoaffinity labeling produced results in close agreement with more conventional methods for studying halothane binding, and should be a useful tool for the study of volatile anesthetic binding sites. Halothane binding to soluble proteins depended on their type and conformation, and, in some cases, was saturable within the clinical concentration range, increasing the tenability of discrete proteinaceous sites of action for the inhalational anesthetics.
最近,已使用核磁共振和气相色谱法证明氟烷和异氟烷以可饱和方式与血清白蛋白结合。为验证我们实验室开发的一种新型直接光亲和标记方法,作者还确定了氟烷与血清白蛋白的结合特性,然后将此方法扩展至其他可溶性蛋白质,初步尝试了解挥发性麻醉剂与蛋白质的相互作用。
将血清白蛋白(牛血清白蛋白)、细菌荧光素酶、聚-L-赖氨酸和聚-L-谷氨酸溶解于含有14C-氟烷的0.154 M氯化钠中,添加或不添加其他挥发性麻醉剂或配体,然后暴露于254 nm紫外光下10秒。沉淀、过滤和洗涤后,通过闪烁计数对共价结合的标记物进行定量。通过对矩形双曲线或逻辑方程进行非线性最小二乘拟合来计算结合参数。
血清白蛋白以可饱和方式结合氟烷,表观解离常数介于0.3至0.5 mM之间。其他挥发性麻醉剂抑制结合(抑制常数,单位为mM):氟烷(0.36)、氯仿(1.26)、甲氧氟烷(2.66)、异氟烷(1.47)、乙醚(45.5)和乙醇(1040)。油酸和牛血清白蛋白构象变化(低pH值)也抑制标记物掺入。在pH值为7时与细菌荧光素酶和聚-L-赖氨酸的结合不饱和,且未被未标记的氟烷或细菌荧光素酶底物癸醛取代。聚-L-赖氨酸转变为α-螺旋构象(pH值>10)会增加结合,并产生一个表观解离常数为0.55 mM的可饱和成分。碱性条件下与聚-L-谷氨酸的结合减少,这与α-螺旋结构域的丧失一致。
光亲和标记产生的结果与研究氟烷结合的更传统方法密切一致,应成为研究挥发性麻醉剂结合位点的有用工具。氟烷与可溶性蛋白质的结合取决于其类型和构象,在某些情况下,在临床浓度范围内是可饱和的,这增加了吸入麻醉剂离散蛋白质作用位点的合理性。